Synthesis and evaluation of tripeptidyl α-ketoamides as human rhinovirus 3C protease inhibitors

被引:25
作者
Chen, SH [1 ]
Lamar, J
Victor, F
Snyder, N
Johnson, R
Heinz, BA
Wakulchik, M
Wang, QM
机构
[1] Lilly Corp Ctr, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA
[2] Lilly Corp Ctr, Lilly Res Labs, Dept Infect Dis, Indianapolis, IN 46285 USA
关键词
D O I
10.1016/S0960-894X(03)00753-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We describe herein the synthesis and biological evaluation of a series of tripeptidyl alpha-ketoamides as human rhinovirus (HRV) 3C protease inhibitors. The most potent inhibitor discussed in this manuscript, 41, exhibited impressive enzyme inhibitory activity as well as antiviral activity against HRV-14. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3531 / 3536
页数:6
相关论文
共 27 条
[1]  
BABINE R, 2002, Patent No. 0218369
[2]   NEW METHOD FOR DEOXYGENATION OF SECONDARY ALCOHOLS [J].
BARTON, DHR ;
MCCOMBIE, SW .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1975, (16) :1574-1585
[3]   The diisopropylcarbodiimide/1-hydroxy-7-azabenzotriazole system: Segment coupling and stepwise peptide assembly [J].
Carpino, LA ;
El-Faham, A .
TETRAHEDRON, 1999, 55 (22) :6813-6830
[4]  
CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062
[5]   PYBOP - A NEW PEPTIDE COUPLING REAGENT DEVOID OF TOXIC BY-PRODUCT [J].
COSTE, J ;
LENGUYEN, D ;
CASTRO, B .
TETRAHEDRON LETTERS, 1990, 31 (02) :205-208
[6]  
COUCH RB, 1990, VIROLOGY
[7]   READILY ACCESSIBLE 12-I-5 OXIDANT FOR THE CONVERSION OF PRIMARY AND SECONDARY ALCOHOLS TO ALDEHYDES AND KETONES [J].
DESS, DB ;
MARTIN, JC .
JOURNAL OF ORGANIC CHEMISTRY, 1983, 48 (22) :4155-4156
[8]   Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors [J].
Dragovich, PS ;
Zhou, R ;
Webber, SE ;
Prins, TJ ;
Kwok, AK ;
Okano, K ;
Fuhrman, SA ;
Zalman, LS ;
Maldonado, FC ;
Brown, EL ;
Meador, JW ;
Patick, AK ;
Ford, CE ;
Brothers, MA ;
Binford, SL ;
Matthews, DA ;
Ferre, RA ;
Worland, ST .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (01) :45-48
[9]   Recent advances in the development of human rhinovirus 3C protease inhibitors [J].
Dragovich, PS .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (02) :177-184
[10]   Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors.: 4.: Incorporation of P1 lactam moieties as L-glutamine replacements [J].
Dragovich, PS ;
Prins, TJ ;
Zhou, R ;
Webber, SE ;
Marakovits, JT ;
Fuhrman, SA ;
Patick, AK ;
Matthews, DA ;
Lee, CA ;
Ford, CE ;
Burke, BJ ;
Rejto, PA ;
Hendrickson, TF ;
Tuntland, T ;
Brown, EL ;
Meador, JW ;
Ferre, RA ;
Harr, JEV ;
Kosa, MB ;
Worland, ST .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (07) :1213-1224